EVEROLIMUS PREDILECTION TO CAUSE DEEP VENOUS THROMBOSIS (DVT) IN AN ANTI-COAGULATED KIDNEY TRANSPLANT PATIENT

2015 ◽  
Vol 65 (4) ◽  
pp. A47 ◽  
Keyword(s):  
Venous Thrombosis ◽  
Deep Venous Thrombosis ◽  
Kidney Transplant ◽  
Transplant Patient ◽  
Kidney Transplant Patient

scholarly journals How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion

2020 ◽  
Vol 35 (6) ◽  
pp. 899-904 ◽  
Author(s):  
Umberto Maggiore ◽  
Daniel Abramowicz ◽  
Marta Crespo ◽  
Christophe Mariat ◽  
Geir Mjoen ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Expert Opinion ◽  
Transplant Patient ◽  
Kidney Transplant Patient

Tacrolimus—Itraconazole Interaction in a Kidney Transplant Patient

2000 ◽  
Vol 34 (4) ◽  
pp. 536-536 ◽  
Author(s):  
María Outeda Macías ◽  
Pilar Salvador ◽  
Juan L Hurtado ◽  
Isabel Martín
Keyword(s):  
Kidney Transplant ◽  
Transplant Patient ◽  
Kidney Transplant Patient

scholarly journals POS-720 Atypical Cause of Pancytopenia in a Kidney Transplant Patient.

2021 ◽  
Vol 6 (4) ◽  
pp. S314-S315
Author(s):  
G. GEMBILLO ◽  
F. D'Ignoto ◽  
P. Salis ◽  
D. Santoro ◽  
R. Liotta ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Transplant Patient ◽  
Kidney Transplant Patient

scholarly journals Transplantation: Polyomavirus Nephropathy and the Risk of Specific Immunosuppression Regimens

2006 ◽  
Vol 6 ◽  
pp. 412-528 ◽  
Author(s):  
Christine Wu ◽  
Parmjeet Randhawa ◽  
Jerry McCauley
Keyword(s):  
Risk Factors ◽  
Renal Transplant ◽  
Kidney Transplant ◽  
Transplant Patient ◽  
Graft Loss ◽  
Bk Virus ◽  
Therapeutic Monitoring ◽  
Kidney Transplant Patient ◽  
Bk Polyomavirus ◽  
Specific Immunosuppression

BK virus is ubiquitously present in the latent state in humans, and awareness of the importance of BK polyomavirus is emerging among the kidney transplant community. First discovered in 1971 in the urine of a renal transplant recipient, BK virus nephropathy (BKVN) has come to be recognized as a significant cause of genitourinary disease and potential graft loss in the kidney transplant patient. In this review, we discuss the risk factors, available methods of diagnosis and therapeutic monitoring, and current approaches to therapy of BKVN.

scholarly journals Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient

2002 ◽  
Vol 97 (5) ◽  
pp. 751-753 ◽  
Author(s):  
Célia MF Gontijo ◽  
Raquel S Pacheco ◽  
Fernando Oréfice ◽  
Euler Lasmar ◽  
Eduardo S Silva ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Transplant Patient ◽  
Kidney Transplant Patient

scholarly journals Intensive Observation of Toxic Side Effects After Several-Year of Cyclosporin Treatment in Kidney Transplant Patient

2007 ◽  
Vol 7 (2) ◽  
pp. 134-137 ◽  
Author(s):  
Mensura Ašćerić ◽  
Sevleta Avdić ◽  
Sabrija Nukić ◽  
Muamera Vrabac-Mujčinagić
Keyword(s):  
Side Effects ◽  
Kidney Transplant ◽  
Transplant Patient ◽  
Daily Basis ◽  
Kidney Transplant Patient ◽  
Arterial Blood ◽  
Cyclosporine Therapy ◽  
Intensive Observation ◽  
Medium Time ◽  
Diastolic Arterial Blood Pressure

In this work we are going to show results of intensive observation of adverse reactions of cyclosporine therapy during 18 months. The research was applied on 30 patients with kidney transplant. The medium time of kidney transplant survival was 9,7+/-2,3 years, with time span of 6 to 15 years. All the patients were subjects to several years' cyclosporine treatment, which was applied on a daily basis with a dosage of 2 to 5 mg/kg of body weight. The concentration of cyclosporine in blood was measured once a month. The concentration of cyclosporine in blood in 19 patients was in referent values of 122,50 nag/ml up to 280,50 nag/ml of blood. In 4 of the patients the concentration was heightened up to 370 to 538 nag/ml (X=766,37 nag/ml), and in 7 patients cyclosporine was below normal dosage down to 30,78 to 96,30 nag/ml in blood (x=77,12 nag/ml). We noticed these toxic side effects: increased values of systolic and diastolic arterial blood pressure in 5 patients, neurotoxic tremor effects in 4 patients, hyperplasia gingival and hirsute in 1 patient each.

Sign in / Sign up

Export Citation Format

Share Document